UCB Expands Patient Support with Hidradenitis Suppurativa Scholarship Program

Event summary

  • UCB launched the Hidradenitis Suppurativa Scholarship™ Program on June 1, 2026, offering up to 11 scholarships for adults with HS and their immediate family members.
  • Applications are open from June 1 to September 1, 2026, via www.ucbhsscholarship.com.
  • The program aims to ease financial burdens for education and career development, including undergraduate, graduate, and certification programs.
  • This initiative builds on UCB's existing scholarship programs for myasthenia gravis and epilepsy communities.

The big picture

UCB's new scholarship program for hidradenitis suppurativa patients aligns with its broader strategy of supporting underserved communities in the biopharmaceutical sector. By investing in education and career development, UCB aims to address the significant life impacts of chronic diseases, potentially enhancing patient loyalty and brand reputation. This move also underscores a growing trend among biopharma companies to integrate patient support into their corporate social responsibility efforts.

What we're watching

Program Impact
How the scholarship program will affect educational and career outcomes for HS patients and their families.
Community Engagement
Whether UCB can sustain long-term engagement with the HS community through this and other initiatives.
Strategic Expansion
The pace at which UCB will expand similar programs to other patient communities it serves.